Kamal Abbi, MD | Green Bay Oncology

CAR T-cell Therapy: From “Dead Man Walking” to Living Proof

Join Dr. Kamal Abbi and Dr. Brad Heraly as they welcome patient Alan Frey to the studio for a raw and insightful look at his experience with CAR T-cell therapy for leukemia.

Is Chemo Worse than Cancer?

Dr. Edgard Badine, Dr. Kamal Abbi, and Dr. Matthew Ryan address the common fear that chemotherapy might be more damaging than the cancer it treats.

The discussion centers on dismantling outdated stigmas and highlighting how modern medicine has shifted the patient experience from one of endurance to one of managed care.

Dr. Edgard Badine, Dr. Kamal Abbi, and Dr. Matthew Ryan discuss why the fear of cancer as a “death sentence” still persists, how modern advances in screening, treatment, and care have reshaped outcomes, and how shifting the conversation toward understanding a patient’s plan can replace fear with clarity and control.

From Patient to Professor: Dr. Brian Merkel and the Transplant Ripple Effect

Dr. Fred Appelbaum, Executive Vice President of Fred Hutch Cancer Center, joins Green Bay Oncology physicians Dr. Brian Burnette, Dr. Kamal Abbi, and Dr. Evan Wenig, along with Dr. Brian Merkel, Professor and Chair of Human Biology at the University of Wisconsin–Green Bay, to reflect on one of the earliest eras of bone marrow transplantation through the eyes of both patient and physician.

The Leukemia Patient Experience

Dr. Fred Appelbaum joins Green Bay Oncology physicians Dr. Brian Burnette, Dr. Kamal Abbi, Dr. Evan Wenig, and UW–Green Bay professor Dr. Brian Merkel to explore how leukemia treatment has evolved—highlighting rising survival rates, the emotional realities of care, and the innovations reshaping hope for patients and families.

A History of Stem Cell Transplantation

Listen as Dr. Fred Appelbaum reflects on the bold and uncertain early days of stem cell transplantation as he and his team at The Hutch helped reshape the treatment of leukemia. From experimental procedures in the 1970s to today’s highly refined transplant and cellular therapies, this conversation traces how risk, collaboration, and perseverance laid the foundation for modern cancer care.

Survivorship and Living with Cancer

Medical oncologists Dr. Brian Burnette and Dr. Kamal Abbi explore the “survivorship cliff,” addressing the emotional and physical challenges patients face when transitioning from active treatment to a new normal.

BiTE Therapy

Dr. Kamal Abbi and Dr. Brian Burnette discuss BiTE therapy, a cutting-edge immunotherapy that brings the body’s own T-cells into direct contact with cancer cells to destroy them. They highlight its rapid advancements and the potential to transform certain incurable cancers into curable diseases with time-limited treatment.

Pluvicto for Advanced Prostate Cancer

Dr. Michael Guiou, Dr. Kamal Abbi, and Dr. Matthew Ryan discuss Pluvicto, an innovative radiopharmaceutical treatment for advanced prostate cancer that delivers targeted radiation throughout the body with fewer side effects than traditional chemotherapy.

Cancer Treatment Safety: Smarter, Not Stronger

Dr. Michael Guiou, Dr. Matthew Ryan, and Dr. Kamal Abbi discuss the key factors that impact the safety and effectiveness of cancer treatments, emphasizing the importance of patient advocacy, understanding treatment options, and working with a multidisciplinary care team.